Cyberknife® system: a new therapeutic strategy for sinonasal solitary extramedullary plasmacytomae.

Related Articles

Cyberknife® system: a new therapeutic strategy for sinonasal solitary extramedullary plasmacytomae.

J Biol Regul Homeost Agents. 2017 Jul-Sep;31(3):763-768

Authors: Cantone E, Borzillo V, Di Lullo AM, Marano L, Guadagno E, Mansueto G, Di Franco R, Cammarota F, Catalano L, Muto P, Iengo M

Abstract
Sino-nasal solitary extramedullary plasmacytoma (EMP) is a rare neoplasm with unpredictable progression to multiple myeloma. To improve the precision of irradiation delivery, preserving the healthy surrounding tissue and critical structures we used a CyberKnife® for the treatment of sinonasal solitary extramedullary plasmacytoma. We present the first case of sinonasal-EMP treated with CyberKnife®-stereotactic radiotherapy (SRT) with a complete remission without adverse events. Based on the post-therapeutic results and healthy tissue preservation, we believe that CyberKnife®-SRT represents a good therapeutic option for the treatment of sinonasal-EMP.

PMID: 28958136 [PubMed - indexed for MEDLINE]

http://ift.tt/2B6NGGB